Crowe Christopher S, Chiou Grace, McGoldrick Rory, Hui Kenneth, Pham Hung, Chang James
Stanford and Palo Alto, Calif. From the Division of Plastic and Reconstructive Surgery, Stanford University Medical Center; and the Division of Plastic and Reconstructive Surgery, Veterans Affairs Palo Alto Health Care System.
Plast Reconstr Surg. 2015 Jun;135(6):981e-989e. doi: 10.1097/PRS.0000000000001268.
Tendon hydrogel is a promising new injectable substance that has been shown to improve repair strength after tendon injury. This study assesses the capacity of platelet-rich plasma to stimulate proliferation and migration of rat adipose-derived stem cells in tendon hydrogel in vitro.
To assess proliferation, adipose-derived stem cells were exposed to plasma, plasma supplemented with growth factors, or platelet-rich plasma in culture medium and tendon hydrogel. To assess migration, adipose-derived stem cells were plated onto tendon hydrogel -coated wells and covered with medium containing plasma, plasma supplemented with growth factors, platelet-rich plasma, or bovine serum albumin. Migration from cell-seeded to cell-free zones was assessed at 12-hour intervals.
Platelet-rich plasma augmented proliferation to a greater extent compared with plasma and plasma supplemented with growth factors (10%: optical density, 1.18 versus 0.75 versus 0.98, respectively). Platelet-rich plasma was superior to plasma in tendon hydrogel (10%: optical density, 1.19 versus 0.85) but did not augment proliferation to the extent that plasma supplemented with growth factors did (10%: optical density, 1.19 versus 1.56). Platelet-rich plasma enhanced the migration of adipose-derived stem cells compared with serum-free medium (bovine serum albumin) (36 hours: platelet-rich plasma, 1.88; plasma, 1.51; plasma plus growth factor, 1.80; bovine serum albumin, 1.43).
Tendon healing is mediated by migration of cells to the injured area and cellular proliferation at that site. Tendon hydrogel supplemented with platelet-rich plasma stimulates these processes. Future studies will evaluate this combination's ability to stimulate healing in chronic tendon injuries in vivo.
肌腱水凝胶是一种很有前景的新型可注射物质,已被证明可提高肌腱损伤后的修复强度。本研究评估富血小板血浆在体外刺激大鼠脂肪来源干细胞在肌腱水凝胶中增殖和迁移的能力。
为评估增殖情况,将脂肪来源干细胞置于培养基和肌腱水凝胶中,分别暴露于血浆、添加生长因子的血浆或富血小板血浆中。为评估迁移情况,将脂肪来源干细胞接种到涂有肌腱水凝胶的孔中,并用含有血浆、添加生长因子的血浆、富血小板血浆或牛血清白蛋白的培养基覆盖。每隔12小时评估从细胞接种区到无细胞区的迁移情况。
与血浆和添加生长因子的血浆相比,富血小板血浆在更大程度上促进了增殖(10%时:光密度分别为1.18、0.75和0.98)。在肌腱水凝胶中,富血小板血浆优于血浆(10%时:光密度为1.19对0.85),但促进增殖的程度不如添加生长因子的血浆(10%时:光密度为1.19对1.56)。与无血清培养基(牛血清白蛋白)相比,富血小板血浆增强了脂肪来源干细胞的迁移(36小时时:富血小板血浆为1.88;血浆为1.51;血浆加生长因子为1.80;牛血清白蛋白为1.43)。
肌腱愈合是由细胞向损伤区域的迁移和该部位的细胞增殖介导的。补充富血小板血浆的肌腱水凝胶可刺激这些过程。未来的研究将评估这种组合在体内刺激慢性肌腱损伤愈合的能力。